Acadia Healthcare Company, Inc.
ACHC- Exchange
- Nasdaq
- Industry
- Services-Specialty Outpatient Facilities, NEC
- SEC CIK
- 0001520697
No open-market purchases or sales by Acadia Healthcare Company, Inc. insiders were filed in the last 90 days; 314 institutions reported holding it in 13F filings for Q2 2026, worth $3.98B in total; Greenlight Capital is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:17 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 13, 2025 | Feb 27, 2024 | Feb 27, 2023 | Feb 28, 2022 |
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B |
| Selling, general and administrative | $177.6M | $156.8M | $153.3M | $124.3M | $108.2M |
| Income tax | $26.0M | $77.4M | -$9.70M | $94.1M | $67.6M |
| Net income | -$1.10B | $255.6M | -$21.7M | $273.1M | $190.6M |
| EPS, basic | $-12.16 | $2.79 | $-0.24 | $3.05 | $2.15 |
| EPS, diluted | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 |
| Weighted shares, basic | 90.7M | 91.6M | 90.9M | 89.7M | 88.8M |
| Weighted shares, diluted | 90.7M | 92.1M | 90.9M | 91.6M | 90.8M |
| Margins and growth | |||||
| Net margin | -33.3% | 8.1% | -0.7% | 10.5% | 8.2% |
| Revenue growth, year over year | +5.0% | +7.7% | +12.2% | +12.8% | +10.7% |
| Net income growth, year over year | −531.4% | – | −107.9% | +43.3% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025! | FY2024! | FY2023! | FY2022! | FY2021! |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 13, 2025 | Feb 27, 2024 | Feb 27, 2023 | Feb 28, 2022 |
| Cash and equivalents | $133.2M | $76.3M | $100.1M | $97.6M | $133.8M |
| Accounts receivable | $440.6M | $365.3M | $361.5M | $322.4M | $281.3M |
| Inventory | $5.69M | $5.65M | $5.30M | $5.09M | $4.79M |
| Total current assets | $814.1M | $577.5M | $596.0M | $506.1M | $495.0M |
| Property, plant and equipment | $3.11B | $2.85B | $2.27B | $1.95B | $1.77B |
| Goodwill | $1.30B | $2.26B | $2.23B | $2.22B | $2.20B |
| Intangible assets | $96.7M | $70.0M | $73.3M | $76.0M | $70.1M |
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B |
| Accounts payable | $150.4M | $232.7M | $156.1M | $104.7M | $98.6M |
| Short-term debt | $28.4M | $76.8M | $29.2M | $21.3M | $18.6M |
| Total current liabilities | $525.2M | $577.9M | $885.8M | $388.3M | $404.9M |
| Long-term debt | $2.47B | $1.88B | $1.34B | $1.36B | $1.48B |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B |
| Shareholders' equity | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 13, 2025 | Feb 27, 2024 | Feb 27, 2023 | Feb 28, 2022 |
| Operating cash flow | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M |
| Capital expenditures | $571.8M | $690.4M | $424.1M | $296.1M | $244.8M |
| Free cash flow | -$439.9M | -$560.7M | $38.2M | $84.4M | $129.7M |
| Depreciation and amortization | $189.2M | $149.6M | $132.3M | $117.8M | $106.7M |
| Stock-based compensation | $31.7M | $37.1M | $32.3M | $29.6M | $37.5M |
| Share buybacks | $50.0M | – | – | – | – |
| Investing cash flow | -$556.2M | -$736.5M | -$397.2M | -$305.8M | $1.02B |
| Financing cash flow | $481.3M | $583.0M | -$62.7M | -$110.9M | -$1.64B |
| Net change in cash | $56.9M | -$23.8M | $2.42M | -$36.2M | -$244.9M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.0% | 1.2% | 1.1% | 1.1% | 1.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 3, 2026 | 93.0M | +0.8% | SEC |
| Jul 27, 2026 | 93.1M | +0.8% | SEC |
| Feb 25, 2026 | 92.2M | −0.8% | SEC |
| Nov 4, 2025 | 92.3M | −0.7% | SEC |
| Aug 5, 2025 | 92.3M | −0.6% | SEC |
| May 12, 2025 | 92.1M | −0.7% | SEC |
| Feb 27, 2025 | 92.9M | +0.7% | SEC |
| Oct 30, 2024 | 92.9M | +0.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.